scholarly article | Q13442814 |
P356 | DOI | 10.1111/AJT.12122 |
P698 | PubMed publication ID | 23465023 |
P50 | author | AST Infectious Diseases Community of Practice | Q103441299 |
P2093 | author name string | D Kumar | |
L Danziger-Isakov | |||
P2860 | cites work | Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipients. | Q30403135 |
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients | Q30403833 | ||
Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group | Q30596624 | ||
Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients | Q32101608 | ||
Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains | Q33902702 | ||
A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings | Q33908062 | ||
Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera | Q34787413 | ||
Smallpox vaccination and the patient with an organ transplant | Q35081771 | ||
Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults | Q35148060 | ||
Hepatitis B vaccination in heart transplant candidates | Q36363374 | ||
Update on immunizations in solid organ transplant recipients: what clinicians need to know | Q37037796 | ||
Efficacy and safety of measles, mumps, rubella and varicella live viral vaccines in transplant recipients receiving immunosuppressive drugs | Q37357139 | ||
Influenza vaccination in the organ transplant recipient: review and summary recommendations. | Q37940524 | ||
An update on immunizations before and after transplantation in the pediatric solid organ transplant recipient | Q37960153 | ||
Rotavirus shedding in premature infants following first immunization | Q40314650 | ||
Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. | Q40486515 | ||
Pretransplant varicella vaccination is cost-effective in pediatric renal transplantation | Q43548974 | ||
Immunity to poliomyelitis, diphtheria and tetanus in pediatric patients before and after renal or liver transplantation | Q43710585 | ||
Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease | Q44079686 | ||
Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age. | Q45367150 | ||
Live virus immunization after orthotopic liver transplantation | Q45419473 | ||
Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults | Q45744556 | ||
The immunogenicity of influenza virus vaccine in solid organ transplant recipients | Q45767721 | ||
Influenza vaccination is efficacious and safe in renal transplant recipients | Q46830965 | ||
Measles-associated encephalopathy in children with renal transplants | Q48547066 | ||
Typhoid fever vaccines | Q50121814 | ||
Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. | Q50762814 | ||
Influenza vaccination following liver transplantation in children. | Q50927965 | ||
Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. | Q52975848 | ||
Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic. | Q53144149 | ||
Are booster immunisations needed for lifelong hepatitis B immunity? | Q54226776 | ||
Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. | Q54702181 | ||
Immunogenicity and Safety of an Intradermal Boosting Strategy for Vaccination Against Influenza in Lung Transplant Recipients | Q58075108 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | organ transplantation | Q69253852 |
P304 | page(s) | 311-317 | |
P577 | publication date | 2013-03-01 | |
P1433 | published in | American Journal of Transplantation | Q4744273 |
P1476 | title | Vaccination in solid organ transplantation | |
P478 | volume | 13 Suppl 4 |
Q41757754 | A cross-sectional study of tetanus and diphtheria antibody concentrations post vaccination among lung transplant patients compared with healthy individuals |
Q39662181 | A quality improvement initiative to increase pneumococcal vaccination coverage among children after kidney transplant |
Q59353208 | An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients |
Q39958646 | Antibody responses to influenza vaccine in pre- and post-lung transplant patients |
Q38459121 | Assessing pharmacologic and nonpharmacologic risks in candidates for kidney transplantation |
Q38593255 | Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications |
Q48118017 | Barriers to vaccination in renal transplant recipients. |
Q38225998 | Changing face of vaccination in immunocompromised hosts |
Q39290443 | Clinical Characteristics and Outcomes of Influenza A Infection in Kidney Transplant Recipients: A Single-Center Experience |
Q38978203 | Comprehensive Care of the Lung Transplant Patient |
Q47572587 | Dermatological Complications After Solid Organ Transplantation |
Q40418678 | Determinants of influenza vaccination among solid organ transplant recipients attending Sicilian reference center |
Q38205920 | Diarrhea caused by viruses in transplant recipients |
Q35930589 | Disseminated Streptococcus pneumoniae infection involving a ventricular assist device |
Q41544620 | Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination |
Q90565344 | Effectiveness Analysis of the Immunization Against Hepatitis B in Liver Transplantation Patients |
Q87644212 | Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation |
Q37211401 | Evaluation of Reference Centers for Special Immunobiologicals implementation |
Q89488088 | Expanding transplant pharmacist presence in pretransplantation ambulatory care |
Q94416613 | Guidelines for vaccination in kidney transplant recipients |
Q45341969 | Hepatitis B Virus Immunization Before and After Pediatric Liver Transplantation: Check, Catch-Up, and Check Again! |
Q38844564 | Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center |
Q40590036 | Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes. |
Q41528126 | High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients |
Q49741477 | High prevalence of hepatitis B-antibody loss and a case report of de novo hepatitis B virus infection in a child after living-donor liver transplantation |
Q90179483 | Human Papillomavirus Vaccination in Male and Female Adolescents Before and After Kidney Transplantation: A Pediatric Nephrology Research Consortium Study |
Q40443403 | Immune status assessment in adult lung transplant candidates |
Q38235003 | Immunization after kidney transplantation-what is necessary and what is safe? |
Q88702475 | Immunization of the immunocompromised child: Key principles |
Q39568995 | Immunization practices among pediatric transplant hepatologists |
Q37320197 | Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review |
Q91287438 | Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial |
Q48177071 | Impact of a pharmacist-led vaccine recommendation program for pediatric kidney transplant candidates |
Q30372284 | Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients. |
Q41923147 | Incomplete vaccination coverage in European children with end-stage kidney disease prior to renal transplantation. |
Q90517160 | Infectious diseases consult improves vaccination adherence in kidney transplant candidates |
Q38602985 | Influenza and other respiratory virus infections in solid organ transplant recipients |
Q42239906 | Influenza vaccination in oncology patients |
Q63753859 | Is there evidence for efficacy of human papillomavirus vaccination in solid organ transplant recipients? |
Q38419551 | Live virus vaccines in transplantation: friend or foe? |
Q38605855 | Low rates of vaccination in listed kidney transplant candidates |
Q94047993 | L’immunisation de l’enfant immunodéprimé : les principes fondamentaux |
Q38125555 | Microbes and allogeneic transplantation. |
Q26825833 | Norovirus infection in immunocompromised hosts |
Q40140647 | Poor positive predictive value of influenza-like illness criteria in adult transplant patients: a case for multiplex respiratory virus PCR testing |
Q41927260 | Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management. |
Q92457037 | Prevalence and clinical impact of Streptococcus pneumoniae nasopharyngeal carriage in solid organ transplant recipients |
Q55084357 | Recent advances in understanding and managing infectious diseases in solid organ transplant recipients. |
Q51016038 | Reply to L'Huillier et al. |
Q47583282 | Respiratory Viral Infections in Solid Organ and Hematopoietic Stem Cell Transplantation |
Q38988696 | Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation |
Q38360594 | Rotavirus in organ transplantation: drug-virus-host interactions. |
Q54265837 | Seasonal influenza vaccine in immunocompromised persons. |
Q59358227 | Seroprevalence of antibodies against the three serotypes of poliovirus and IPV vaccine response in adult solid organ transplant candidates |
Q39195792 | Simultaneous Occurrence of Varicella Zoster Virus-Induced Pancreatitis and Hepatitis in a Renal Transplant Recipient: A Case Report and Review of Literature |
Q92178995 | The situation of vaccines for the prevention of infections in adults: An opinion paper on the situation in Spain |
Q38511222 | Transplantation in the tropics: lessons on prevention and management of tropical infectious diseases |
Q27687760 | Travel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measures |
Q92079541 | Under-immunization of pediatric transplant recipients: a call to action for the pediatric community |
Q35521863 | Updated data on effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation |
Q55505646 | Vaccination practices in End Stage Renal Failure and Renal Transplantation; Review of current guidelines and recommendations. |
Q47555615 | Vaccination titres pre- and post-transplant in paediatric renal transplant recipients and the impact of immunosuppressive therapy |
Q40960257 | Vaccinations in children on immunosuppressive medications for renal disease |
Q61447873 | Vaccinations in kidney transplant recipients: Clearing the muddy waters |
Q54232660 | Vaccinations in pediatric kidney transplant recipients. |
Q38256131 | Vaccine administration in children with chronic kidney disease |
Q38569825 | Vaccine-preventable infection morbidity of patients with chronic kidney disease and cocoon vaccination strategies |
Q41337536 | Value of solid organ transplant-trained pharmacists in transplant infectious diseases |
Q90447834 | Varicella infections in patients with end stage renal disease: a systematic review |
Q33595211 | Waning of vaccine-induced immunity to measles in kidney transplanted children. |
Search more.